MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma

ABSTRACT:

SUBMITTER: Leoni I 

PROVIDER: S-EPMC12027541 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature